vs
Rhinebeck Bancorp, Inc.（RBKB）与瓦里安医疗系统（UTMD）财务数据对比。点击上方公司名可切换其他公司
Rhinebeck Bancorp, Inc.的季度营收约是瓦里安医疗系统的1.5倍（$13.5M vs $9.0M），瓦里安医疗系统净利率更高（28.4% vs 17.3%，领先11.1%），Rhinebeck Bancorp, Inc.同比增速更快（1701.1% vs -1.2%），Rhinebeck Bancorp, Inc.自由现金流更多（$10.9M vs $3.4M），过去两年Rhinebeck Bancorp, Inc.的营收复合增速更高（14.0% vs -10.7%）
Rhinebeck Bancorp, Inc.是总部位于美国纽约的区域性银行控股企业，旗下运营莱茵贝克银行，主要面向纽约哈德逊谷地区的个人消费者与中小企业提供储蓄、贷款、抵押贷款、财富管理等零售及商业金融服务。
瓦里安医疗系统是一家总部位于美国加利福尼亚州帕洛阿尔托的肿瘤放射治疗设备与软件制造商，其产品包括直线加速器以及用于放射治疗、放射外科、质子治疗、短距离放射治疗等癌症及其他病症治疗的相关软件，同时为癌症诊疗中心、放射治疗中心提供运营管理软件，全球员工规模超过7100人。
RBKB vs UTMD — 直观对比
营收规模更大
RBKB
是对方的1.5倍
$9.0M
营收增速更快
RBKB
高出1702.3%
-1.2%
净利率更高
UTMD
高出11.1%
17.3%
自由现金流更多
RBKB
多$7.5M
$3.4M
两年增速更快
RBKB
近两年复合增速
-10.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $9.0M |
| 净利润 | $2.3M | $2.6M |
| 毛利率 | — | 58.2% |
| 营业利润率 | 21.7% | 27.0% |
| 净利率 | 17.3% | 28.4% |
| 营收同比 | 1701.1% | -1.2% |
| 净利润同比 | 188.0% | -11.6% |
| 每股收益（稀释后） | $0.21 | $0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RBKBUTMD
| Q4 25 | $13.5M | $9.0M | ||
| Q3 25 | $14.0M | $9.8M | ||
| Q2 25 | $13.1M | $10.0M | ||
| Q1 25 | $12.8M | $9.7M | ||
| Q4 24 | $750.0K | $9.2M | ||
| Q3 24 | $773.0K | $10.0M | ||
| Q2 24 | $10.7M | $10.4M | ||
| Q1 24 | $10.4M | $11.3M |
净利润RBKBUTMD
| Q4 25 | $2.3M | $2.6M | ||
| Q3 25 | $2.7M | $2.6M | ||
| Q2 25 | $2.7M | $3.0M | ||
| Q1 25 | $2.3M | $3.0M | ||
| Q4 24 | $-2.7M | $2.9M | ||
| Q3 24 | $-8.1M | $3.6M | ||
| Q2 24 | $975.0K | $3.5M | ||
| Q1 24 | $1.1M | $4.0M |
毛利率RBKBUTMD
| Q4 25 | — | 58.2% | ||
| Q3 25 | — | 57.1% | ||
| Q2 25 | — | 56.2% | ||
| Q1 25 | — | 57.0% | ||
| Q4 24 | — | 58.1% | ||
| Q3 24 | — | 58.0% | ||
| Q2 24 | — | 60.1% | ||
| Q1 24 | — | 59.7% |
营业利润率RBKBUTMD
| Q4 25 | 21.7% | 27.0% | ||
| Q3 25 | 23.9% | 26.6% | ||
| Q2 25 | 26.6% | 32.1% | ||
| Q1 25 | 22.9% | 32.5% | ||
| Q4 24 | -444.9% | 32.0% | ||
| Q3 24 | -1332.3% | 33.4% | ||
| Q2 24 | 11.8% | 33.1% | ||
| Q1 24 | 13.9% | 34.2% |
净利率RBKBUTMD
| Q4 25 | 17.3% | 28.4% | ||
| Q3 25 | 19.3% | 26.8% | ||
| Q2 25 | 20.8% | 30.6% | ||
| Q1 25 | 17.9% | 31.3% | ||
| Q4 24 | -353.9% | 31.7% | ||
| Q3 24 | -1042.9% | 35.6% | ||
| Q2 24 | 9.2% | 33.2% | ||
| Q1 24 | 10.8% | 34.9% |
每股收益（稀释后）RBKBUTMD
| Q4 25 | $0.21 | $0.80 | ||
| Q3 25 | $0.25 | $0.82 | ||
| Q2 25 | $0.25 | $0.94 | ||
| Q1 25 | $0.21 | $0.92 | ||
| Q4 24 | $-0.24 | $0.86 | ||
| Q3 24 | $-0.75 | $1.03 | ||
| Q2 24 | $0.09 | $0.98 | ||
| Q1 24 | $0.10 | $1.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $85.8M |
| 总债务越低越好 | — | $225.0K |
| 股东权益账面价值 | $136.9M | $119.3M |
| 总资产 | $1.3B | $122.5M |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资RBKBUTMD
| Q4 25 | — | $85.8M | ||
| Q3 25 | — | $84.3M | ||
| Q2 25 | — | $82.2M | ||
| Q1 25 | — | $83.3M | ||
| Q4 24 | — | $83.0M | ||
| Q3 24 | — | $88.5M | ||
| Q2 24 | — | $89.2M | ||
| Q1 24 | — | $93.8M |
总债务RBKBUTMD
| Q4 25 | — | $225.0K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $269.0K | ||
| Q4 24 | — | $282.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RBKBUTMD
| Q4 25 | $136.9M | $119.3M | ||
| Q3 25 | $133.0M | $118.3M | ||
| Q2 25 | $129.0M | $117.5M | ||
| Q1 25 | $126.0M | $117.0M | ||
| Q4 24 | $121.8M | $117.4M | ||
| Q3 24 | $122.7M | $124.2M | ||
| Q2 24 | $116.2M | $124.1M | ||
| Q1 24 | $114.3M | $127.7M |
总资产RBKBUTMD
| Q4 25 | $1.3B | $122.5M | ||
| Q3 25 | $1.3B | $122.0M | ||
| Q2 25 | $1.3B | $120.8M | ||
| Q1 25 | $1.3B | $122.5M | ||
| Q4 24 | $1.3B | $122.5M | ||
| Q3 24 | $1.3B | $129.7M | ||
| Q2 24 | $1.3B | $130.0M | ||
| Q1 24 | $1.3B | $135.4M |
负债/权益比RBKBUTMD
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.7M | $3.5M |
| 自由现金流经营现金流 - 资本支出 | $10.9M | $3.4M |
| 自由现金流率自由现金流/营收 | 80.6% | 37.2% |
| 资本支出强度资本支出/营收 | 6.3% | 1.2% |
| 现金转化率经营现金流/净利润 | 5.03× | 1.36× |
| 过去12个月自由现金流最近4个季度 | $19.4M | $14.3M |
8季度趋势，按日历期对齐
经营现金流RBKBUTMD
| Q4 25 | $11.7M | $3.5M | ||
| Q3 25 | $2.2M | $3.9M | ||
| Q2 25 | $2.4M | $2.9M | ||
| Q1 25 | $4.3M | $4.5M | ||
| Q4 24 | $8.5M | $2.9M | ||
| Q3 24 | $-3.6M | $3.9M | ||
| Q2 24 | $12.0M | $2.8M | ||
| Q1 24 | $-3.5M | $5.3M |
自由现金流RBKBUTMD
| Q4 25 | $10.9M | $3.4M | ||
| Q3 25 | $2.0M | $3.9M | ||
| Q2 25 | $2.2M | $2.8M | ||
| Q1 25 | $4.2M | $4.3M | ||
| Q4 24 | $7.7M | $2.9M | ||
| Q3 24 | $-3.6M | $3.8M | ||
| Q2 24 | $11.8M | $2.7M | ||
| Q1 24 | $-3.7M | $5.3M |
自由现金流率RBKBUTMD
| Q4 25 | 80.6% | 37.2% | ||
| Q3 25 | 14.5% | 39.2% | ||
| Q2 25 | 17.2% | 28.4% | ||
| Q1 25 | 32.8% | 44.1% | ||
| Q4 24 | 1023.9% | 32.0% | ||
| Q3 24 | -469.0% | 37.7% | ||
| Q2 24 | 111.1% | 25.5% | ||
| Q1 24 | -36.0% | 46.3% |
资本支出强度RBKBUTMD
| Q4 25 | 6.3% | 1.2% | ||
| Q3 25 | 1.4% | 0.3% | ||
| Q2 25 | 1.4% | 0.5% | ||
| Q1 25 | 0.9% | 1.9% | ||
| Q4 24 | 105.5% | 0.1% | ||
| Q3 24 | 6.3% | 0.9% | ||
| Q2 24 | 1.2% | 1.1% | ||
| Q1 24 | 2.3% | 0.2% |
现金转化率RBKBUTMD
| Q4 25 | 5.03× | 1.36× | ||
| Q3 25 | 0.83× | 1.47× | ||
| Q2 25 | 0.89× | 0.94× | ||
| Q1 25 | 1.89× | 1.47× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.08× | ||
| Q2 24 | 12.27× | 0.80× | ||
| Q1 24 | -3.12× | 1.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
